HYPOXIC-ISCHEMIC BRAIN INJURY IN THE NEONATALPERIOD – CURRENT CONCEPTS, NOVEL DIAGNOSTICAPPROACHES AND NEUROPROTECTIVE STRATEGIES*
Abstract
In the presenting paper, we describe mechanisms of brain injury following a hypoxicischemic event in the neonatal period. Neuronal death occurs in two major phases, theprimary neuronal cell loss at the time of the insult and the delayed neuronal cell loss, occurring about 6 hours – 4 days after the injury. We describe different cellular mechanismsresponsible for the neuronal death. The main patterns of brain injury that can be readilyrecognized with the newer neuroimaging techniques are dependent on the gestationalage of the newborn. In order to apply novel neuroprotective treatments to the newbornswith hypoxic-ischemic encephalopathy (HIE), the newborns at risk have to be identified asearly as possible. Among the most useful diagnostic methods are amplitude-integrated EEG,new markers of brain lesions and different modalities of magnetic-resonance imaging.During resuscitation of neonates with HIE the importance of prevention of hyperoxia,and, during intensive care, of hypocapnia and hyperglycemia is stressed. In the treatmentof newborns with HIE hypothermia, by means of both selective head cooling or whole bodyhypothermia, reduced the risk of death and disability according to three multicenterrandomized controlled studies. It is therefore recommended for treatment of HIE in thenewborn. One of the potentially beneficial effects of therapeutic hypothermia is also widening of the therapeutic window for intervention with other neuroprotective regimens. Amongthese, treatments with erythropoietin or minocycline seem to be clinically promising.Downloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.